# Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device

> **NCT03925324** · PHASE2 · TERMINATED · sponsor: **Medstar Health Research Institute** · enrollment: 4 (actual)

## Conditions studied

- Ischemic Heart Disease
- Non-ischemic Cardiomyopathy

## Interventions

- **BIOLOGICAL:** Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03925324
- **Lead sponsor:** Medstar Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-03
- **Primary completion:** 2021-08-16
- **Final completion:** 2021-08-16
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Lack of funding/Covid-19
- **Last updated:** 2022-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03925324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03925324, "Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03925324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*